Description
BSE announces listing of 2000 bonus equity shares of Sun Pharmaceutical Industries Ltd. kept in abeyance, effective January 12, 2026.
Summary
BSE has announced the listing of 2000 bonus equity shares of Sun Pharmaceutical Industries Ltd. (Scrip Code: 524715) that were previously kept in abeyance. These shares will be listed and permitted to trade with effect from Monday, January 12, 2026.
Key Points
- 2000 bonus equity shares of Rs. 1/- each to be listed
- Company: Sun Pharmaceutical Industries Ltd.
- Scrip Code: 524715
- ISIN: INE044A01036
- Trading commencement date: January 12, 2026
- Shares were previously kept in abeyance
Share Details
Distinctive Number Ranges:
- 1000 shares: Distinctive No. 1035573706 to 1035574705
- 1000 shares: Distinctive No. 1042698157 to 1042699156
Regulatory Changes
No regulatory changes introduced. This is a standard listing notification for bonus shares that were previously held in abeyance.
Compliance Requirements
Trading members are informed to note the listing of these securities for trading purposes effective from the specified date.
Important Dates
- Notice Date: January 9, 2026
- Listing and Trading Commencement: January 12, 2026 (Monday)
Impact Assessment
Minimal market impact expected as this involves a small quantity of bonus shares (2000 shares) that were previously kept in abeyance. This is an administrative action to release shares that were held pending resolution of specific issues. The limited number of shares will have negligible effect on Sun Pharma’s overall trading or market capitalization.
Impact Justification
Administrative listing of small number of bonus shares previously kept in abeyance; minimal market impact due to limited quantity (2000 shares)